Comparison
Why is Geron Corp. ?
- NET SALES(HY) Higher at USD 88.64 MM
- ROCE(HY) Highest at -31.09%
- OPERATING PROFIT(Q) Highest at USD -12.15 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -71.71%, its profits have risen by 31.8%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Along with generating -71.71% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Geron Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Geron Corp. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at USD 88.64 MM
Highest at -31.09%
Highest at USD -12.15 MM
Highest at USD -16.38 MM
Highest at USD -16.38 MM
Fallen by -98.1% (YoY
Highest at 0.13 times
Highest at 7.74 times
Highest at USD -0.02
At USD 16.72 MM has Grown at 147.57%
Highest at -53.96 %
Here's what is working for Geron Corp.
Net Sales (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Geron Corp.
Interest Paid (USD MM)
Debt-Equity Ratio






